2024 ASCO GU Cancers Symposium
The 2024 American Society of Clinical Oncology GU Cancers Symposium, taking place January 25-27, 2024, provides the latest updates on treatment, research, and care for genitourinary cancers. The symposium features panel discussions, presentations, poster sessions, and more opportunities to learn about new developments in the field.
The use of the blood-based test, which was validated in the SEPTA trial, could reduce the number of biopsies needed.
These measurements can help clinicians understand if a treatment is making a patient's life better, longer, or both.
Christopher Wallis, MD, PhD, FRCSC, and Karen Hoffman, MD, MHSc, MPH, discuss patient-reported outcomes from the trial.
Learn how a team implemented a program to address challenges experienced by patients with prostate cancer.
A new study highlights the need for “further efforts and policy changes” to improve access to end-of-life care.
The rash management protocol was implemented in the phase II Apa-RP study.
Ongoing work is exploring the relationship between resilience and different domains of frailty.
Advertisement
Advertisement
